Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > News > Insert Therapeutics Files IND Application

February 9th, 2006

Insert Therapeutics Files IND Application

Abstract:
Arrowhead Research Corporation (Nasdaq:ARWR) announced today that its majority-owned subsidiary Insert Therapeutics, Inc. has submitted an investigational new drug application (IND) to the U.S. Food and Drug Administration (FDA) for IT-101, its first anti-cancer drug candidate. Cyclosert is a proprietary drug delivery technology based on a nano-engineered class of linear cyclodextrin polymers.

Source:
businesswire

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

'Atomic chicken-wire' is key to faster DNA sequencing March 30th, 2015

Novel nanoparticle therapy promotes wound healing March 27th, 2015

Graphene reduces wear of alumina ceramic March 26th, 2015

Application of Graphene Oxide in Body Implants in Iran March 26th, 2015

Announcements

'Atomic chicken-wire' is key to faster DNA sequencing March 30th, 2015

Nanoscale worms provide new route to nano-necklace structures March 29th, 2015

Solving molybdenum disulfide's 'thin' problem: Research team increases material's light emission by twelve times March 29th, 2015

A first glimpse inside a macroscopic quantum state March 28th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE